188 related articles for article (PubMed ID: 29722173)
21. Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel NONO-TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum.
Wang XT; Xia QY; Ni H; Wang ZY; Ye SB; Li R; Wang X; Lv JH; Shi SS; Ma HH; Lu ZF; Shen Q; Zhou XJ; Rao Q
Histopathology; 2016 Sep; 69(3):450-8. PubMed ID: 26844676
[TBL] [Abstract][Full Text] [Related]
22. Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.
Chen X; Yang Y; Gan W; Xu L; Ye Q; Guo H
Medicine (Baltimore); 2015 May; 94(19):e873. PubMed ID: 25984679
[TBL] [Abstract][Full Text] [Related]
23. Imprint cytologic features in renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in an adult: a case report.
Yamaguchi T; Kuroda N; Imamura Y; Hes O; Kawada T; Nakayama K
Acta Cytol; 2009; 53(6):693-7. PubMed ID: 20014561
[TBL] [Abstract][Full Text] [Related]
24. Bilateral Xp11.2 translocation renal cell carcinoma: a case report.
Karashima T; Kuno T; Kuroda N; Satake H; Fukata S; Chikazawa M; Kawada C; Yamasaki I; Shuin T; Hiroi M; Inoue K
BMC Urol; 2018 Nov; 18(1):106. PubMed ID: 30458744
[TBL] [Abstract][Full Text] [Related]
25. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
[TBL] [Abstract][Full Text] [Related]
26. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
[TBL] [Abstract][Full Text] [Related]
27. [Application of polyclonal break-apart probes in the diagnosis of Xp11.2 translocation renal cell carcinoma].
Chen X; Gan W; Ye Q; Yang J; Guo H; Li D
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3675-7. PubMed ID: 25622964
[TBL] [Abstract][Full Text] [Related]
28. Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification.
Wang XT; Xia QY; Zhou XJ; Rao Q
Crit Rev Oncog; 2017; 22(5-6):481-497. PubMed ID: 29604926
[TBL] [Abstract][Full Text] [Related]
29. Cytopathology of Xp11 translocation renal cell carcinoma: a report of 5 cases.
Jin M; Parwani A; Li Z; Wakely PE
J Am Soc Cytopathol; 2020; 9(2):95-102. PubMed ID: 32029406
[TBL] [Abstract][Full Text] [Related]
30. RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.
Argani P; Zhang L; Reuter VE; Tickoo SK; Antonescu CR
Am J Surg Pathol; 2017 May; 41(5):655-662. PubMed ID: 28296677
[TBL] [Abstract][Full Text] [Related]
31. An adult case of melanotic Xp11 translocation renal cancers: distinct entity or sub-entity?
Varinot J; Camparo P; Beurtheret S; Barreda E; Compérat E
Int J Surg Pathol; 2011 Jun; 19(3):285-9. PubMed ID: 21427096
[TBL] [Abstract][Full Text] [Related]
32. Melanotic MiT family translocation neoplasms: Expanding the clinical and molecular spectrum of this unique entity of tumors.
Saleeb RM; Srigley JR; Sweet J; Doucet C; Royal V; Chen YB; Brimo F; Evans A
Pathol Res Pract; 2017 Nov; 213(11):1412-1418. PubMed ID: 28969862
[TBL] [Abstract][Full Text] [Related]
33. Unsuspected Xp11 Translocation Renal Neoplasm Associated With Contralateral Clear Cell Carcinoma.
D'Antonio A; Addesso M; Nappi O; Zeppa P
Int J Surg Pathol; 2016 May; 24(3):248-52. PubMed ID: 26729550
[TBL] [Abstract][Full Text] [Related]
34. A case of TFE3 translocation renal cell carcinoma with rare morphological features and literature review.
Xia T; Long H; Liao D; Wang W; Xiao X
Indian J Pathol Microbiol; 2023; 66(1):135-140. PubMed ID: 36656224
[TBL] [Abstract][Full Text] [Related]
35. Combination of immunohistochemistry, FISH and RT-PCR shows high incidence of Xp11 translocation RCC: comparison of three different diagnostic methods.
Lee HJ; Shin DH; Noh GY; Kim YK; Kim A; Shin N; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Rha SH; Park SW
Oncotarget; 2017 May; 8(19):30756-30765. PubMed ID: 28415646
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population.
Qu Y; Gu C; Wang H; Chang K; Yang X; Zhou X; Dai B; Zhu Y; Shi G; Zhang H; Ye D
Sci Rep; 2016 Feb; 6():21677. PubMed ID: 26880493
[TBL] [Abstract][Full Text] [Related]
37. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review.
He J; Chen X; Gan W; Zhu B; Fan X; Guo H; Jia R
Future Oncol; 2015; 11(24):3243-52. PubMed ID: 26169997
[TBL] [Abstract][Full Text] [Related]
38. Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3.
Xia QY; Wang XT; Zhan XM; Tan X; Chen H; Liu Y; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
Am J Surg Pathol; 2017 May; 41(5):663-676. PubMed ID: 28288037
[TBL] [Abstract][Full Text] [Related]
39. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X
Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774
[TBL] [Abstract][Full Text] [Related]
40. [Xp11 neoplasma with melanocytic differentiation: a clinicopathological analysis].
Wang XT; Zhang RS; Li R; Ye SB; Wang X; Xia QY; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2019 Dec; 48(12):945-950. PubMed ID: 31818068
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]